Barosi G - Search Results

1

SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.

Corradini P, Marchetti M, Barosi G, Billio A, Gallamini A, Pileri S, Pimpinelli N, Rossi G, Zinzani PL, Tura S. Corradini P, et al. Among authors: barosi g. Ann Oncol. 2014 Dec;25(12):2339-2350. doi: 10.1093/annonc/mdu152. Epub 2014 Apr 9. Ann Oncol. 2014. PMID: 24723488 Free article.

2

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines.

Santini V, Alessandrino PE, Angelucci E, Barosi G, Billio A, Di Maio M, Finelli C, Locatelli F, Marchetti M, Morra E, Musto P, Visani G, Tura S; Italian Society of Hematology. Santini V, et al. Among authors: barosi g. Leuk Res. 2010 Dec;34(12):1576-88. doi: 10.1016/j.leukres.2010.01.018. Epub 2010 Feb 11. Leuk Res. 2010. PMID: 20149927

3

Cost-effectiveness of epoetin and autologous blood donationin reducing allogeneic blood transfusions incoronary artery bypass graft surgery.

Marchetti M, Barosi G. Marchetti M, et al. Among authors: barosi g. Transfusion. 2000 Jun;40(6):673-81. doi: 10.1046/j.1537-2995.2000.40060673.x. Transfusion. 2000. PMID: 10864987

4

Guidelines for the use of recombinant human erythropoietin.

Barosi G, Cazzola M, De Vincentiis A, Grossi A, Tura S. Barosi G, et al. Haematologica. 1994 Nov-Dec;79(6):526-33. Haematologica. 1994. PMID: 7896210 No abstract available.

5

Beyond Bayes.

Marchetti M, Liberato NL, Barosi G. Marchetti M, et al. Among authors: barosi g. Haematologica. 1996 May-Jun;81(3):253-7. Haematologica. 1996. PMID: 8767531 No abstract available.

6

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.

Barosi G, Marchetti M, Liberato NL. Barosi G, et al. Br J Cancer. 1998 Sep;78(6):781-7. doi: 10.1038/bjc.1998.579. Br J Cancer. 1998. PMID: 9743301 Free PMC article.

7

Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios.

Marchetti M, Quaglini S, Barosi G. Marchetti M, et al. Among authors: barosi g. J Intern Med. 1998 Sep;244(3):217-26. doi: 10.1046/j.1365-2796.1998.00362.x. J Intern Med. 1998. PMID: 9747744 Free article.

8

Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden--cost-effectiveness analysis.

Marchetti M, Pistorio A, Barosi G. Marchetti M, et al. Among authors: barosi g. Thromb Haemost. 2000 Nov;84(5):752-7. Thromb Haemost. 2000. PMID: 11127850

9

Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.

Marchetti M, Quaglini S, Barosi G. Marchetti M, et al. Among authors: barosi g. QJM. 2001 Jul;94(7):365-72. doi: 10.1093/qjmed/94.7.365. QJM. 2001. PMID: 11435632 Review.

10

Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacement.

Marchetti M, Liberato NL, Ruperto N, Barosi G. Marchetti M, et al. Among authors: barosi g. Haematologica. 1999 Aug;84(8):730-7. Haematologica. 1999. PMID: 10458700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters